| Mrs Brandi Nicole Pleming, FNP | |
|
3515 Richland Ave, Aiken, SC 29801 | |
| (803) 642-2626 | |
| (803) 648-2960 |
| Full Name | Mrs Brandi Nicole Pleming |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 6 Years |
| Location | 3515 Richland Ave, Aiken, South Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1992299150 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | RN217363 (Georgia) | Secondary |
| 363LF0000X | Nurse Practitioner - Family | 22059 (South Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Hospital | Augusta, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Umg Prompt Care South Carolina Llc | 9830401660 | 26 |
News Archive
Today, IMBRUVICA (ibrutinib) was awarded the prestigious Prix Galien USA 2015 Award in the category of Best Pharmaceutical Agent. The Prix Galien Award is considered to be the industry's highest accolade and recognizes the vital technical, scientific and clinical research skills necessary to develop medicines.
The increased activation of a key oncogene in head and neck cancers could be the result of mutation and dysfunction of regulatory proteins that are supposed to keep the gene, which has the potential to cause cancer, in check, according to a new study led by researchers at the University of Pittsburgh School of Medicine.
Reading, one of the most difficult activities for children with dyslexia, can be improved by the use of green filters.
Adamas Pharmaceuticals, Inc., a privately held company, announced today that it has closed a $40 million Series D round of funding led by aeris CAPITAL AG and DAG Ventures. Earlier investors MDV-Mohr Davidow Ventures and Northgate Capital also participated in the round. In conjunction with the financing, the company announced the election of George M. Rehm, Managing Partner of aeris CAPITAL AG, and David L. Mahoney, a private equity investor, to the company's Board of Directors.
› Verified 4 days ago
| Entity Name | Umg Prompt Care South Carolina Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629462122 PECOS PAC ID: 9830401660 Enrollment ID: O20150707002716 |
News Archive
Today, IMBRUVICA (ibrutinib) was awarded the prestigious Prix Galien USA 2015 Award in the category of Best Pharmaceutical Agent. The Prix Galien Award is considered to be the industry's highest accolade and recognizes the vital technical, scientific and clinical research skills necessary to develop medicines.
The increased activation of a key oncogene in head and neck cancers could be the result of mutation and dysfunction of regulatory proteins that are supposed to keep the gene, which has the potential to cause cancer, in check, according to a new study led by researchers at the University of Pittsburgh School of Medicine.
Reading, one of the most difficult activities for children with dyslexia, can be improved by the use of green filters.
Adamas Pharmaceuticals, Inc., a privately held company, announced today that it has closed a $40 million Series D round of funding led by aeris CAPITAL AG and DAG Ventures. Earlier investors MDV-Mohr Davidow Ventures and Northgate Capital also participated in the round. In conjunction with the financing, the company announced the election of George M. Rehm, Managing Partner of aeris CAPITAL AG, and David L. Mahoney, a private equity investor, to the company's Board of Directors.
› Verified 4 days ago
| Entity Name | Umg Primary Care South Carolina Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1851747190 PECOS PAC ID: 0244523959 Enrollment ID: O20160718002103 |
News Archive
Today, IMBRUVICA (ibrutinib) was awarded the prestigious Prix Galien USA 2015 Award in the category of Best Pharmaceutical Agent. The Prix Galien Award is considered to be the industry's highest accolade and recognizes the vital technical, scientific and clinical research skills necessary to develop medicines.
The increased activation of a key oncogene in head and neck cancers could be the result of mutation and dysfunction of regulatory proteins that are supposed to keep the gene, which has the potential to cause cancer, in check, according to a new study led by researchers at the University of Pittsburgh School of Medicine.
Reading, one of the most difficult activities for children with dyslexia, can be improved by the use of green filters.
Adamas Pharmaceuticals, Inc., a privately held company, announced today that it has closed a $40 million Series D round of funding led by aeris CAPITAL AG and DAG Ventures. Earlier investors MDV-Mohr Davidow Ventures and Northgate Capital also participated in the round. In conjunction with the financing, the company announced the election of George M. Rehm, Managing Partner of aeris CAPITAL AG, and David L. Mahoney, a private equity investor, to the company's Board of Directors.
› Verified 4 days ago
| Entity Name | Piedmont Professional Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104088905 PECOS PAC ID: 8921176231 Enrollment ID: O20240213001704 |
News Archive
Today, IMBRUVICA (ibrutinib) was awarded the prestigious Prix Galien USA 2015 Award in the category of Best Pharmaceutical Agent. The Prix Galien Award is considered to be the industry's highest accolade and recognizes the vital technical, scientific and clinical research skills necessary to develop medicines.
The increased activation of a key oncogene in head and neck cancers could be the result of mutation and dysfunction of regulatory proteins that are supposed to keep the gene, which has the potential to cause cancer, in check, according to a new study led by researchers at the University of Pittsburgh School of Medicine.
Reading, one of the most difficult activities for children with dyslexia, can be improved by the use of green filters.
Adamas Pharmaceuticals, Inc., a privately held company, announced today that it has closed a $40 million Series D round of funding led by aeris CAPITAL AG and DAG Ventures. Earlier investors MDV-Mohr Davidow Ventures and Northgate Capital also participated in the round. In conjunction with the financing, the company announced the election of George M. Rehm, Managing Partner of aeris CAPITAL AG, and David L. Mahoney, a private equity investor, to the company's Board of Directors.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Brandi Nicole Pleming, FNP Po Box 1705, Augusta, GA 30903-1705 Ph: (706) 774-7263 | Mrs Brandi Nicole Pleming, FNP 3515 Richland Ave, Aiken, SC 29801 Ph: (803) 642-2626 |
News Archive
Today, IMBRUVICA (ibrutinib) was awarded the prestigious Prix Galien USA 2015 Award in the category of Best Pharmaceutical Agent. The Prix Galien Award is considered to be the industry's highest accolade and recognizes the vital technical, scientific and clinical research skills necessary to develop medicines.
The increased activation of a key oncogene in head and neck cancers could be the result of mutation and dysfunction of regulatory proteins that are supposed to keep the gene, which has the potential to cause cancer, in check, according to a new study led by researchers at the University of Pittsburgh School of Medicine.
Reading, one of the most difficult activities for children with dyslexia, can be improved by the use of green filters.
Adamas Pharmaceuticals, Inc., a privately held company, announced today that it has closed a $40 million Series D round of funding led by aeris CAPITAL AG and DAG Ventures. Earlier investors MDV-Mohr Davidow Ventures and Northgate Capital also participated in the round. In conjunction with the financing, the company announced the election of George M. Rehm, Managing Partner of aeris CAPITAL AG, and David L. Mahoney, a private equity investor, to the company's Board of Directors.
› Verified 4 days ago
Lindsay K Pizzuto, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 415 Barnwell Ave Nw, Aiken, SC 29801 Phone: 803-644-4403 Fax: 803-644-4405 | |
Catherine Rutherfurd Rudnick, MSN, FNP-C Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 222 Beaufort St Ne, Aiken, SC 29801 Phone: 803-502-4685 | |
Sarah Brennan Heilig, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1029 York St Ne, Aiken, SC 29801 Phone: 803-648-4119 | |
Kristin Braveboy Haddock, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 420 Society Hill Dr Ste 100, Aiken, SC 29803 Phone: 803-648-7774 Fax: 803-648-7490 | |
Amaya Edge, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2062 Whiskey Rd, Aiken, SC 29803 Phone: 980-205-5134 | |
Mrs. Ashley Protzman, NP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 850 Aiken Mall Dr, Aiken, SC 29803 Phone: 803-648-1464 | |
Ms. Tracy Stichert, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 415 Barnwell Ave Nw, Aiken, SC 29801 Phone: 803-641-4403 Fax: 803-644-4405 |